-
1
-
-
84862000390
-
Cystic fibrosis and other channelopathies
-
Edelman, A., and Saussereau, E. (2012) Cystic fibrosis and other channelopathies. Arch. Pediatr. 19, Suppl. 1, S13-S16
-
(2012)
Arch. Pediatr.
, vol.19
, pp. S13-S16
-
-
Edelman, A.1
Saussereau, E.2
-
2
-
-
0032721451
-
Low bone mineral density in adults with cystic fibrosis
-
Haworth, C. S., Selby, P. L., Webb, A. K., Dodd, M. E., Musson, H., Niven, R., Economou, G., Horrocks, A. W., Freemont, A. J., Mawer, E. B., and Adams, J. E. (1999) Low bone mineral density in adults with cystic fibrosis. Thorax 54, 961-967
-
(1999)
Thorax
, vol.54
, pp. 961-967
-
-
Haworth, C.S.1
Selby, P.L.2
Webb, A.K.3
Dodd, M.E.4
Musson, H.5
Niven, R.6
Economou, G.7
Horrocks, A.W.8
Freemont, A.J.9
Mawer, E.B.10
Adams, J.E.11
-
3
-
-
0033837182
-
Osteoporosis and osteopenia in adults and adolescents with cystic fibrosis: Prevalence and associated factors
-
Conway, S. P., Morton, A. M., Oldroyd, B., Truscott, J. G., White, H., Smith, A. H., and Haigh, I. (2000) Osteoporosis and osteopenia in adults and adolescents with cystic fibrosis: prevalence and associated factors. Thorax 55, 798-804
-
(2000)
Thorax
, vol.55
, pp. 798-804
-
-
Conway, S.P.1
Morton, A.M.2
Oldroyd, B.3
Truscott, J.G.4
White, H.5
Smith, A.H.6
Haigh, I.7
-
4
-
-
34247642182
-
Low bone mineral density in young children with cystic fibrosis
-
Sermet-Gaudelus, I., Souberbielle, J. C., Ruiz, J. C., Vrielynck, S., Heuillon, B., Azhar, I., Cazenave, A., Lawson-Body, E., Chedevergne, F., and Lenoir, G. (2007) Low bone mineral density in young children with cystic fibrosis. Am. J. Respir. Crit. Care Med. 175, 951-957
-
(2007)
Am. J. Respir. Crit. Care Med.
, vol.175
, pp. 951-957
-
-
Sermet-Gaudelus, I.1
Souberbielle, J.C.2
Ruiz, J.C.3
Vrielynck, S.4
Heuillon, B.5
Azhar, I.6
Cazenave, A.7
Lawson-Body, E.8
Chedevergne, F.9
Lenoir, G.10
-
5
-
-
73649105431
-
The prevalence of osteoporosis, osteopenia, and fractures among adults with cystic fibrosis: A systematic literature review with meta-analysis
-
Paccou, J., Zeboulon, N., Combescure, C., Gossec, L., and Cortet, B. (2010) The prevalence of osteoporosis, osteopenia, and fractures among adults with cystic fibrosis: a systematic literature review with meta-analysis. Calcif. Tissue Int. 86, 1-7
-
(2010)
Calcif. Tissue Int.
, vol.86
, pp. 1-7
-
-
Paccou, J.1
Zeboulon, N.2
Combescure, C.3
Gossec, L.4
Cortet, B.5
-
6
-
-
84855702423
-
Bone loss in adults with cystic fibrosis: Prevalence, associated factors, and usefulness of biological markers
-
Legroux-Gérot, I., Leroy, S., Prudhomme, C., Perez, T., Flipo, R. M., Wallaert, B., and Cortet, B. (2012) Bone loss in adults with cystic fibrosis: prevalence, associated factors, and usefulness of biological markers. Joint Bone Spine 79, 73-77
-
(2012)
Joint Bone Spine
, vol.79
, pp. 73-77
-
-
Legroux-Gérot, I.1
Leroy, S.2
Prudhomme, C.3
Perez, T.4
Flipo, R.M.5
Wallaert, B.6
Cortet, B.7
-
7
-
-
77955497814
-
Cellular and molecular mechanisms of bone remodeling
-
Raggatt, L. J., and Partridge, N. C. (2010) Cellular and molecular mechanisms of bone remodeling. J. Biol. Chem. 285, 25103-25108
-
(2010)
J. Biol. Chem.
, vol.285
, pp. 25103-25108
-
-
Raggatt, L.J.1
Partridge, N.C.2
-
8
-
-
34447325620
-
Cystic fibrosis transmembrane conductance regulator (CFTR) is expressed in human bone
-
Shead, E. F., Haworth, C. S., Condliffe, A. M., McKeon, D. J., Scott, M. A., and Compston, J. E. (2007) Cystic fibrosis transmembrane conductance regulator (CFTR) is expressed in human bone. Thorax 62, 650-651
-
(2007)
Thorax
, vol.62
, pp. 650-651
-
-
Shead, E.F.1
Haworth, C.S.2
Condliffe, A.M.3
McKeon, D.J.4
Scott, M.A.5
Compston, J.E.6
-
9
-
-
77950529656
-
The cystic fibrosis transmembrane conductance regulator (CFTR) is expressed in maturation stage ameloblasts, odontoblasts and bone cells
-
Bronckers, A., Kalogeraki, L., Jorna, H. J., Wilke, M., Bervoets, T. J., Lyaruu, D. M., Zandieh-Doulabi, B., Denbesten, P., and de Jonge, H. (2010) The cystic fibrosis transmembrane conductance regulator (CFTR) is expressed in maturation stage ameloblasts, odontoblasts and bone cells. Bone 46, 1188-1196
-
(2010)
Bone
, vol.46
, pp. 1188-1196
-
-
Bronckers, A.1
Kalogeraki, L.2
Jorna, H.J.3
Wilke, M.4
Bervoets, T.J.5
Lyaruu, D.M.6
Zandieh-Doulabi, B.7
Denbesten, P.8
De Jonge, H.9
-
10
-
-
84893370295
-
Osteoblast CFTR inactivation reduces differentiation and osteoprotegerin expression in a mouse model of cystic fibrosis-related bone disease
-
Stalvey, M. S., Clines, K. L., Havasi, V., McKibbin, C. R., Dunn, L. K., Chung, W. J., and Clines, G. A. (2013) Osteoblast CFTR inactivation reduces differentiation and osteoprotegerin expression in a mouse model of cystic fibrosis-related bone disease. PLoS ONE 8, e80098
-
(2013)
PLoS ONE
, vol.8
, pp. e80098
-
-
Stalvey, M.S.1
Clines, K.L.2
Havasi, V.3
McKibbin, C.R.4
Dunn, L.K.5
Chung, W.J.6
Clines, G.A.7
-
11
-
-
4344707707
-
Severe osteopenia in CFTR-null mice
-
Dif, F., Marty, C., Baudoin, C., de Vernejoul, M. C., and Levi, G. (2004) Severe osteopenia in CFTR-null mice. Bone 35, 595-603
-
(2004)
Bone
, vol.35
, pp. 595-603
-
-
Dif, F.1
Marty, C.2
Baudoin, C.3
De Vernejoul, M.C.4
Levi, G.5
-
12
-
-
33846117944
-
Cystic fibrosis mouse models
-
Guilbault, C., Saeed, Z., Downey, G. P., and Radzioch, D. (2007) Cystic fibrosis mouse models. Am. J. Respir. Cell Mol. Biol. 36, 1-7
-
(2007)
Am. J. Respir. Cell Mol. Biol.
, vol.36
, pp. 1-7
-
-
Guilbault, C.1
Saeed, Z.2
Downey, G.P.3
Radzioch, D.4
-
13
-
-
38849119609
-
Persistent osteopenia in adult cystic fibrosis transmembrane conductance regulator-deficient mice
-
Haston, C. K., Li, W., Li, A., Lafleur, M., and Henderson, J. E. (2008) Persistent osteopenia in adult cystic fibrosis transmembrane conductance regulator-deficient mice. Am. J. Respir. Crit. Care Med. 177, 309-315
-
(2008)
Am. J. Respir. Crit. Care Med.
, vol.177
, pp. 309-315
-
-
Haston, C.K.1
Li, W.2
Li, A.3
Lafleur, M.4
Henderson, J.E.5
-
14
-
-
61949178361
-
Murine model for cystic fibrosis bone disease demonstrates osteopenia and sex-related differences in bone formation
-
Pashuck, T. D., Franz, S. E., Altman, M. K., Wasserfall, C. H., Atkinson, M. A., Wronski, T. J., Flotte, T. R., and Stalvey, M. S. (2009) Murine model for cystic fibrosis bone disease demonstrates osteopenia and sex-related differences in bone formation. Pediatr. Res. 65, 311-316
-
(2009)
Pediatr. Res.
, vol.65
, pp. 311-316
-
-
Pashuck, T.D.1
Franz, S.E.2
Altman, M.K.3
Wasserfall, C.H.4
Atkinson, M.A.5
Wronski, T.J.6
Flotte, T.R.7
Stalvey, M.S.8
-
15
-
-
77953912807
-
Osteopenia in CFTR-ΔF508 mice
-
Paradis, J., Wilke, M., and Haston, C. K. (2010) Osteopenia in Cftr-ΔF508 mice. J. Cyst. Fibros. 9, 239-245
-
(2010)
J. Cyst. Fibros.
, vol.9
, pp. 239-245
-
-
Paradis, J.1
Wilke, M.2
Haston, C.K.3
-
16
-
-
84860237323
-
The F508del mutation in cystic fibrosis transmembrane conductance regulator gene impacts bone formation
-
Le Henaff, C., Gimenez, A., Haÿ, E., Marty, C., Marie, P., and Jacquot, J. (2012) The F508del mutation in cystic fibrosis transmembrane conductance regulator gene impacts bone formation. Am. J. Pathol. 180, 2068-2075
-
(2012)
Am. J. Pathol.
, vol.180
, pp. 2068-2075
-
-
Le Henaff, C.1
Gimenez, A.2
Haÿ, E.3
Marty, C.4
Marie, P.5
Jacquot, J.6
-
17
-
-
84897857417
-
Enhanced F508del-CFTR channel activity ameliorates bone pathology in murine cystic fibrosis
-
Le Henaff, C., Haÿ, E., Velard, F., Marty, C., Tabary, O., Marie, P. J., and Jacquot, J. P. (2014) Enhanced F508del-CFTR channel activity ameliorates bone pathology in murine cystic fibrosis. Am. J. Pathol. 184, 1132-1141
-
(2014)
Am. J. Pathol.
, vol.184
, pp. 1132-1141
-
-
Le Henaff, C.1
Haÿ, E.2
Velard, F.3
Marty, C.4
Tabary, O.5
Marie, P.J.6
Jacquot, J.P.7
-
18
-
-
70449566790
-
Eicosanoid release is increased by membrane destabilization and CFTR inhibition in Calu-3 cells
-
Borot, F., Vieu, D. L., Faure, G., Fritsch, J., Colas, J., Moriceau, S., Baudouin-Legros, M., Brouillard, F., Ayala-Sanmartin, J., Touqui, L., Chanson, M., Edelman, A., and Ollero, M. (2009) Eicosanoid release is increased by membrane destabilization and CFTR inhibition in Calu-3 cells. PLoS ONE 4, e7116
-
(2009)
PLoS ONE
, vol.4
, pp. e7116
-
-
Borot, F.1
Vieu, D.L.2
Faure, G.3
Fritsch, J.4
Colas, J.5
Moriceau, S.6
Baudouin-Legros, M.7
Brouillard, F.8
Ayala-Sanmartin, J.9
Touqui, L.10
Chanson, M.11
Edelman, A.12
Ollero, M.13
-
19
-
-
84864288310
-
CFTR is a negative regulator of NFκB mediated innate immune response
-
Vij, N., Mazur, S., and Zeitlin, P. L. (2009) CFTR is a negative regulator of NFκB mediated innate immune response. PLoS ONE 4, e4664
-
(2009)
PLoS ONE
, vol.4
, pp. e4664
-
-
Vij, N.1
Mazur, S.2
Zeitlin, P.L.3
-
20
-
-
77956624118
-
The NF-κB signaling in cystic fibrosis lung disease: Pathophysiology and therapeutic potential
-
Bodas, M., and Vij, N. (2010) The NF-κB signaling in cystic fibrosis lung disease: pathophysiology and therapeutic potential. Discov. Med. 9, 346-356
-
(2010)
Discov. Med.
, vol.9
, pp. 346-356
-
-
Bodas, M.1
Vij, N.2
-
21
-
-
30944432774
-
Calcium-dependent regulation of NF-κB activation in cystic fibrosis airway epithelial cells
-
Tabary, O., Boncoeur, E., de Martin, R., Pepperkok, R., Clément, A., Schultz, C., and Jacquot, J. (2006) Calcium-dependent regulation of NF-κB activation in cystic fibrosis airway epithelial cells. Cell. Signal. 18, 652-660
-
(2006)
Cell. Signal.
, vol.18
, pp. 652-660
-
-
Tabary, O.1
Boncoeur, E.2
De Martin, R.3
Pepperkok, R.4
Clément, A.5
Schultz, C.6
Jacquot, J.7
-
22
-
-
77956744791
-
The immune system and bone
-
Pacifici, R. (2010) The immune system and bone. Arch. Biochem. Biophys. 503, 41-53
-
(2010)
Arch. Biochem. Biophys.
, vol.503
, pp. 41-53
-
-
Pacifici, R.1
-
23
-
-
77950640257
-
Functions of nuclear factor-κB in bone
-
Boyce, B. F., Yao, Z., and Xing, L. (2010) Functions of nuclear factor-κB in bone. Ann. N.Y. Acad. Sci. 1192, 367-375
-
(2010)
Ann. N.Y. Acad. Sci.
, vol.1192
, pp. 367-375
-
-
Boyce, B.F.1
Yao, Z.2
Xing, L.3
-
24
-
-
77957587105
-
Novel functions for NFκB: Inhibition of bone formation
-
Krum, S. A., Chang, J., Miranda-Carboni, G., and Wang, C. Y. (2010) Novel functions for NFκB: inhibition of bone formation. Nat. Rev. Rheumatol. 6, 607-611
-
(2010)
Nat. Rev. Rheumatol.
, vol.6
, pp. 607-611
-
-
Krum, S.A.1
Chang, J.2
Miranda-Carboni, G.3
Wang, C.Y.4
-
25
-
-
78650858041
-
Role of NF-κB in the skeleton
-
Novack, D. V. (2011) Role of NF-κB in the skeleton. Cell Res. 21, 169-182
-
(2011)
Cell Res.
, vol.21
, pp. 169-182
-
-
Novack, D.V.1
-
26
-
-
84880139498
-
The role of inflammatory cytokines, the RANKL/OPG axis, and the immunoskeletal interface in physiological bone turnover and osteoporosis
-
Weitzmann, M. N. (2013) The role of inflammatory cytokines, the RANKL/OPG axis, and the immunoskeletal interface in physiological bone turnover and osteoporosis. Scientifica 2013, 125705
-
(2013)
Scientifica
, vol.2013
, pp. 125705
-
-
Weitzmann, M.N.1
-
27
-
-
67349238305
-
Inhibition of osteoblastic bone formation by nuclear factor-κB
-
Chang, J., Wang, Z., Tang, E., Fan, Z., McCauley, L., Franceschi, R., Guan, K., Krebsbach, P. H., and Wang, C. Y. (2009) Inhibition of osteoblastic bone formation by nuclear factor-κB. Nat. Med. 15, 682-689
-
(2009)
Nat. Med.
, vol.15
, pp. 682-689
-
-
Chang, J.1
Wang, Z.2
Tang, E.3
Fan, Z.4
McCauley, L.5
Franceschi, R.6
Guan, K.7
Krebsbach, P.H.8
Wang, C.Y.9
-
28
-
-
84878736561
-
NF-κB inhibits osteogenic differentiation of mesenchymal stem cells by promoting beta-catenin degradation
-
Chang, J., Liu, F., Lee, M., Wu, B., Ting, K., Zara, J. N., Soo, C., Al Hezaimi, K., Zou, W., Chen, X., Mooney, D. J., and Wang, C. Y. (2013) NF-κB inhibits osteogenic differentiation of mesenchymal stem cells by promoting beta-catenin degradation. Proc. Natl. Acad. Sci. U.S.A. 110, 9469-9474
-
(2013)
Proc. Natl. Acad. Sci. U.S.A.
, vol.110
, pp. 9469-9474
-
-
Chang, J.1
Liu, F.2
Lee, M.3
Wu, B.4
Ting, K.5
Zara, J.N.6
Soo, C.7
Al Hezaimi, K.8
Zou, W.9
Chen, X.10
Mooney, D.J.11
Wang, C.Y.12
-
29
-
-
0041845297
-
E3 ubiquitin ligase Smurf1 mediates core-binding factor α1/Runx2 degradation and plays a specific role in osteoblast differentiation
-
Zhao, M., Qiao, M., Oyajobi, B. O., Mundy, G. R., and Chen, D. (2003) E3 ubiquitin ligase Smurf1 mediates core-binding factor α1/Runx2 degradation and plays a specific role in osteoblast differentiation. J. Biol. Chem. 278, 27939-27944
-
(2003)
J. Biol. Chem.
, vol.278
, pp. 27939-27944
-
-
Zhao, M.1
Qiao, M.2
Oyajobi, B.O.3
Mundy, G.R.4
Chen, D.5
-
30
-
-
1842477311
-
Smurf1 inhibits osteoblast differentiation and bone formation in vitro and in vivo
-
Zhao, M., Qiao, M., Harris, S. E., Oyajobi, B. O., Mundy, G. R., and Chen, D. (2004) Smurf1 inhibits osteoblast differentiation and bone formation in vitro and in vivo. J. Biol. Chem. 279, 12854-12859
-
(2004)
J. Biol. Chem.
, vol.279
, pp. 12854-12859
-
-
Zhao, M.1
Qiao, M.2
Harris, S.E.3
Oyajobi, B.O.4
Mundy, G.R.5
Chen, D.6
-
31
-
-
33645226966
-
Tumor necrosis factor promotes Runx2 degradation through up-regulation of Smurf1 and Smurf2 in osteoblasts
-
Kaneki, H., Guo, R., Chen, D., Yao, Z., Schwarz, E. M., Zhang, Y. E., Boyce, B. F., and Xing, L. (2006) Tumor necrosis factor promotes Runx2 degradation through up-regulation of Smurf1 and Smurf2 in osteoblasts. J. Biol. Chem. 281, 4326-4333
-
(2006)
J. Biol. Chem.
, vol.281
, pp. 4326-4333
-
-
Kaneki, H.1
Guo, R.2
Chen, D.3
Yao, Z.4
Schwarz, E.M.5
Zhang, Y.E.6
Boyce, B.F.7
Xing, L.8
-
32
-
-
53149122891
-
Ubiquitin ligase Smurf1 mediates tumor necrosis factor-induced systemic bone loss by promoting proteasomal degradation of bone morphogenetic signaling proteins
-
Guo, R., Yamashita, M., Zhang, Q., Zhou, Q., Chen, D., Reynolds, D. G., Awad, H. A., Yanoso, L., Zhao, L., Schwarz, E. M., Zhang, Y. E., Boyce, B. F., and Xing, L. (2008) Ubiquitin ligase Smurf1 mediates tumor necrosis factor-induced systemic bone loss by promoting proteasomal degradation of bone morphogenetic signaling proteins. J. Biol. Chem. 283, 23084-23092
-
(2008)
J. Biol. Chem.
, vol.283
, pp. 23084-23092
-
-
Guo, R.1
Yamashita, M.2
Zhang, Q.3
Zhou, Q.4
Chen, D.5
Reynolds, D.G.6
Awad, H.A.7
Yanoso, L.8
Zhao, L.9
Schwarz, E.M.10
Zhang, Y.E.11
Boyce, B.F.12
Xing, L.13
-
33
-
-
59449095748
-
N-cadherin interacts with axin and LRP5 to negatively regulate Wnt/β-catenin signaling, osteoblast function, and bone formation
-
Haÿ, E., Laplantine, E., Geoffroy, V., Frain, M., Kohler, T., Müller, R., and Marie, P. J. (2009) N-cadherin interacts with axin and LRP5 to negatively regulate Wnt/β-catenin signaling, osteoblast function, and bone formation. Mol. Cell. Biol. 29, 953-964
-
(2009)
Mol. Cell. Biol.
, vol.29
, pp. 953-964
-
-
Haÿ, E.1
Laplantine, E.2
Geoffroy, V.3
Frain, M.4
Kohler, T.5
Müller, R.6
Marie, P.J.7
-
34
-
-
0027468116
-
Cells isolated from the endosteal bone surface of adult rats express differentiated osteoblastic characteristics in vitro
-
Modrowski, D., and Marie, P. J. (1993) Cells isolated from the endosteal bone surface of adult rats express differentiated osteoblastic characteristics in vitro. Cell Tissue Res. 271, 499-505
-
(1993)
Cell Tissue Res.
, vol.271
, pp. 499-505
-
-
Modrowski, D.1
Marie, P.J.2
-
35
-
-
77249176209
-
Cystic fibrosis transmembrane conductance regulator modulators for personalized drug treatment of cystic fibrosis: Progress to date
-
Becq, F. (2010) Cystic fibrosis transmembrane conductance regulator modulators for personalized drug treatment of cystic fibrosis: progress to date. Drugs 70, 241-259
-
(2010)
Drugs
, vol.70
, pp. 241-259
-
-
Becq, F.1
-
36
-
-
33846049299
-
NF-κB in breast cancer cells promotes osteolytic bone metastasis by inducing osteoclastogenesis via GM-CSF
-
Park, B. K., Zhang, H., Zeng, Q., Dai, J., Keller, E. T., Giordano, T., Gu, K., Shah, V., Pei, L., Zarbo, R. J., McCauley, L., Shi, S., Chen, S., and Wang, C. Y. (2007) NF-κB in breast cancer cells promotes osteolytic bone metastasis by inducing osteoclastogenesis via GM-CSF. Nat. Med. 13, 62-69
-
(2007)
Nat. Med.
, vol.13
, pp. 62-69
-
-
Park, B.K.1
Zhang, H.2
Zeng, Q.3
Dai, J.4
Keller, E.T.5
Giordano, T.6
Gu, K.7
Shah, V.8
Pei, L.9
Zarbo, R.J.10
McCauley, L.11
Shi, S.12
Chen, S.13
Wang, C.Y.14
-
37
-
-
17044462159
-
Interaction between LRP5 and Frat1 mediates the activation of the Wnt canonical pathway
-
Haÿ, E., Faucheu, C., Suc-Royer, I., Touitou, R., Stiot, V., Vayssière, B., Baron, R., Roman-Roman, S., and Rawadi, G. (2005) Interaction between LRP5 and Frat1 mediates the activation of the Wnt canonical pathway. J. Biol. Chem. 280, 13616-13623
-
(2005)
J. Biol. Chem.
, vol.280
, pp. 13616-13623
-
-
Haÿ, E.1
Faucheu, C.2
Suc-Royer, I.3
Touitou, R.4
Stiot, V.5
Vayssière, B.6
Baron, R.7
Roman-Roman, S.8
Rawadi, G.9
-
38
-
-
64149095856
-
Fibroblast growth factor receptor 2 promotes osteogenic differentiation in mesenchymal cells via ERK1/2 and protein kinase C signaling
-
Miraoui, H., Oudina, K., Petite, H., Tanimoto, Y., Moriyama, K., and Marie, P. J. (2009) Fibroblast growth factor receptor 2 promotes osteogenic differentiation in mesenchymal cells via ERK1/2 and protein kinase C signaling. J. Biol. Chem. 284, 4897-4904
-
(2009)
J. Biol. Chem.
, vol.284
, pp. 4897-4904
-
-
Miraoui, H.1
Oudina, K.2
Petite, H.3
Tanimoto, Y.4
Moriyama, K.5
Marie, P.J.6
-
39
-
-
70350020147
-
NEMO specifically recognizes K63-linked polyubiquitin chains through a new bipartite ubiquitin-binding domain
-
Laplantine, E., Fontan, E., Chiaravalli, J., Lopez, T., Lakisic, G., Véron, M., Agou, F., and Israël, A. (2009) NEMO specifically recognizes K63-linked polyubiquitin chains through a new bipartite ubiquitin-binding domain. EMBO J. 28, 2885-2895
-
(2009)
EMBO J.
, vol.28
, pp. 2885-2895
-
-
Laplantine, E.1
Fontan, E.2
Chiaravalli, J.3
Lopez, T.4
Lakisic, G.5
Véron, M.6
Agou, F.7
Israël, A.8
-
40
-
-
0037159513
-
IKKα, IKKβ, and NEMO/IKKγ are each required for the NF-κB-mediated inflammatory response program
-
Li, X., Massa, P. E., Hanidu, A., Peet, G. W., Aro, P., Savitt, A., Mische, S., Li, J., and Marcu, K. B. (2002) IKKα, IKKβ, and NEMO/IKKγ are each required for the NF-κB-mediated inflammatory response program. J. Biol. Chem. 277, 45129-45140
-
(2002)
J. Biol. Chem.
, vol.277
, pp. 45129-45140
-
-
Li, X.1
Massa, P.E.2
Hanidu, A.3
Peet, G.W.4
Aro, P.5
Savitt, A.6
Mische, S.7
Li, J.8
Marcu, K.B.9
-
41
-
-
84873558051
-
WNT signaling in bone homeostasis and disease: From human mutations to treatments
-
Baron, R., and Kneissel, M. (2013) WNT signaling in bone homeostasis and disease: from human mutations to treatments. Nat. Med. 19, 179-192
-
(2013)
Nat. Med.
, vol.19
, pp. 179-192
-
-
Baron, R.1
Kneissel, M.2
-
42
-
-
19644373254
-
Wnt signaling in disease and in development
-
Nusse, R. (2005) Wnt signaling in disease and in development. Cell Res. 15, 28-32
-
(2005)
Cell Res.
, vol.15
, pp. 28-32
-
-
Nusse, R.1
-
43
-
-
33746808398
-
Wnt/β-catenin signaling in development and disease
-
Clevers, H. (2006) Wnt/β-catenin signaling in development and disease. Cell 127, 469-480
-
(2006)
Cell
, vol.127
, pp. 469-480
-
-
Clevers, H.1
-
44
-
-
0037064055
-
Wnt signaling protects 3T3-L1 preadipocytes from apoptosis through induction of insulin-like growth factors
-
Longo, K. A., Kennell, J. A., Ochocinska, M. J., Ross, S. E., Wright, W. S., and MacDougald, O. A. (2002) Wnt signaling protects 3T3-L1 preadipocytes from apoptosis through induction of insulin-like growth factors. J. Biol. Chem. 277, 38239-38244
-
(2002)
J. Biol. Chem.
, vol.277
, pp. 38239-38244
-
-
Longo, K.A.1
Kennell, J.A.2
Ochocinska, M.J.3
Ross, S.E.4
Wright, W.S.5
MacDougald, O.A.6
-
45
-
-
77955382245
-
Expression of wild-type CFTR suppresses NF-κB-driven inflammatory signalling
-
Hunter, M. J., Treharne, K. J., Winter, A. K., Cassidy, D. M., Land, S., and Mehta, A. (2010) Expression of wild-type CFTR suppresses NF-κB-driven inflammatory signalling. PLoS ONE 5, e11598
-
(2010)
PLoS ONE
, vol.5
, pp. e11598
-
-
Hunter, M.J.1
Treharne, K.J.2
Winter, A.K.3
Cassidy, D.M.4
Land, S.5
Mehta, A.6
-
46
-
-
3543045594
-
The fos-related antigen Fra-1 is an activator of bone matrix formation
-
Eferl, R., Hoebertz, A., Schilling, A. F., Rath, M., Karreth, F., Kenner, L., Amling, M., and Wagner, E. F. (2004) The Fos-related antigen Fra-1 is an activator of bone matrix formation. EMBO J. 23, 2789-2799
-
(2004)
EMBO J.
, vol.23
, pp. 2789-2799
-
-
Eferl, R.1
Hoebertz, A.2
Schilling, A.F.3
Rath, M.4
Karreth, F.5
Kenner, L.6
Amling, M.7
Wagner, E.F.8
-
47
-
-
84858706841
-
Cross-regulation between Wnt and NF-κB signaling pathways
-
Du, Q., and Geller, D. A. (2010) Cross-regulation between Wnt and NF-κB signaling pathways. For Immunopathol. Dis. Therap. 1, 155-181
-
(2010)
For Immunopathol. Dis. Therap.
, vol.1
, pp. 155-181
-
-
Du, Q.1
Geller, D.A.2
|